HemaVista careers

Investor Summary: db.tt/N1IcAU1Y

~~~
Donated human blood is the largest generic pharmaceutical drug in the United States, generating over $6 billion in annual sales (the blood you donate at a blood center is sold to hospitals for $160 - $250 per pint). The market for human blood is extremely inefficient, wasteful and ripe for optimization. HemaVista is the solution for this market inefficiency.

Hospitals are wasting billions of dollars on human blood products. Worse yet, most hospital executives don’t realize the severity of the problem.
The inefficiencies and waste can be grouped in the following categories:
• Too many units being thrown away
• Too many units being transfused
• Too many units being erroneously paid for
• Too much spent to acquire the units
• Too many units in inventory, tying up working capital